Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologiesPhilipp Königshofer, Thomas Reiberger, Benedikt Hofer et al.|Hepatology|2021Cited by 52
Nuclear receptors in liver fibrosisPhilipp Königshofer, Thomas Reiberger, Ksenia Brusilovskaya et al.|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2021Cited by 46
Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosisBenedikt Hofer, Thomas Gremmel, Ksenia Brusilovskaya et al.|Hepatology|2023Cited by 17
Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertensionPhilipp Schwabl, Thomas Reiberger, Michael Trauner et al.|Advances in Medical Sciences|2022Cited by 15
Platelet Function Decreases with Increasing Severity of Liver Cirrhosis and Portal Hypertension—A Prospective StudyKsenia Brusilovskaya, Thomas Gremmel, Benedikt Hofer et al.|Thrombosis and Haemostasis|2023Cited by 11